The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases

American Journal of Clinical Pathology

Volumn 119, Issue 4, 2003, Pages 497-504

  Refaai, Majed A ^b   Van Cott, Elizabeth M ^b   Laposata, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Heparin; Heparin induced thrombocytopenia; Platelet count; Thrombocytopenia; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG USE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; TIME; UNITED STATES; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; RETROSPECTIVE STUDY; THROMBOCYTE;

ANTICOAGULANTS; BLOOD PLATELETS; HEPARIN; HUMANS; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; THROMBOSIS; TIME FACTORS;

EID: 85047688014     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KM2Y9H9TP6DA59MT     Document Type: Article

References (29)

1. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1997;79:1-7.
2. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101:502-507.
3. Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol. 1998;35:9-16.
4. Raible MD. Hematologic complications of heparin-induced thrombocytopenia. Semin Thromb Hemost. 1999;25:17-21.
5. Gupta AK, Kovacs MJ, Sauder DN. Heparin-induced thrombocytopenia. Ann Pharmacother. 1998;32:55-59.
6. Warkentin TE. Venous thromboembolism in heparin-induced thrombocytopenia. Curr Opin Pulm Med. 2000;6:343-351.
7. Wallis DE, Workman DL, Lewis BE, et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med. 1999;106:629-635.
8. Caiola E. Heparin-induced thrombocytopenia: how to manage it, how to avoid it. Cleve Clin J Med. 2000;67:621-624.
9. Mammen EE Low molecular weight heparins and heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 1999;5 suppl 1:S72-S75.
10. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
11. Brieger DB, Mak K, Kottke-Marchant K, et al. Heparin-induced thrombocytopenia. J Am Coll Cardiol. 1998;31:1449-1459.
12. Van Damme H, Damas P, David JL, et al. Heparin-induced thrombocytopenia: a case report. Angiology. 1990;41:1075-1081.
13. Babcock RB, Dumper CW, Scharfman WB. Heparin-induced immune thrombocytopenia. N Engl J Med. 1976;295:237-241.
14. Greinacher A, Volpel H, Janssens U, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation. 1999;99:73-80.
15. Mudaliar JH, Liem TK, Nichols WK, et al. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. J Vasc Surg. 2001;34:17-20.
16. Keng TB, Chong BH. Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-hirudin. Br J Haematol. 2001;114:394-396.
17. Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 2001;103:1838-1843.
18. Kondo LM, Wittkowsky AK, Wiggins BS. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia. Ann Pharmacother. 2001;35:440-451.
19. Warkentin TE, Sikov WM, Lillicrap DP. Multicentric warfarin-induced necrosis complicating heparin-induced thrombocytopenia. Am J Hematol. 1999;62:44-48.
20. Warkentin TE. Limitations of conventional treatment options for heparin-induced thrombocytopenia. Semin Hematol. 1998;35:17-25.
21. Walenga JM, Jeska WP, Fasanella AR, et al. Laboratory diagnosis of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 1999;5:21-27.
22. Elalamy I, Lecrubier C, Horellou MH, et al. Heparin-induced thrombocytopenia: laboratory diagnosis and management. Ann Med. 2000;32:60-67.
23. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1995;104:648-654.
24. Chong BH, Eisbacher M. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia. Semin Hematol. 1998;35(4 suppl 5):3-8, 35-36.
25. Baglin TP. Heparin-induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment. J Clin Pathol. 2001;54:272-274.
26. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135:502-506.
27. Refaai MA, Laposata M, Van Cott EM. Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. Am J Clin Pathol. 2003;119:61-65.
28. Chong BH, Pilgrim RL, Cooley MA, et al. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood. 1993;81:988-993.
29. Harenberg J, Huhle G, Giese C, et al. Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol. 2000;109:182-186.